Melanoma, cancer pain management, symptom control, supportive oncology,
general hematology-oncology, palliative medicine
Amy P. Abernethy, MD PhD
Director, Center for Learning Health Care
Director, Duke Cancer Care Research Program
Professor of Medicine, Department of Medicine, Division of Medical Oncology, Duke University School of Medicine
Associate Professor of Nursing, Duke University School of Nursing
Dr. Abernethy, a hematologist/oncologist and palliative care physician, is Professor of Medicine in the Duke University School of Medicine, Director of the Duke Center for Learning Health Care (CLHC) in the Duke Clinical Research Institute, and Director of the Duke Cancer Care Research Program (DCCRP) in the Duke Cancer Institute. With over 375 publications, she is an internationally recognized expert in health services research, comparative effectiveness research, patient reported outcomes (PROs), clinical informatics and patient-centered care.
Dr. Abernethy is an appointee to the Institute of Medicine’s National Cancer Policy Forum, Immediate Past President of the American Academy of Hospice & Palliative Medicine (AAHPM), Secretary of the Board of Directors for the Personalized Medicine Coalition, Co-Chair of the National Institutes of Health (NIH)-funded Palliative Care Research Cooperative Group, Co-Chair of the PRO Core for the NIH Collaboratory Program, and Chair of the PRO Task Force for the Patient Centered Outcomes Research Institute National Clinical Research Network. She Co-Leads the Learning Health System Training Program at Duke. She serves on the Board of Directors for athenahealth. Dr. Abernethy participates integrally in current high-level national and international discussions about reforming the evidence development system, presenting a model for a rapid learning health care that coordinates clinical and research functions to better serve patients’ needs in an evidence-driven, cost-effective, and patient-centered manner.
Clinically, Dr. Abernethy was previously responsible for the care of patients with melanoma, in conjunction with the surgeons and radiation oncologists of the Duke Melanoma Clinic. She is Principal Investigator on major international studies for metastatic melanoma, and has published in areas pertinent to the epidemiology of melanoma, longitudinal care patterns, and improving the melanoma patient experience. Dr. Abernethy also previously attended on Duke's palliative care service, with special focus on improving the quality of life for people affected by advanced cancer including their families. Dr. Abernethy completed medical training, residency, and a fellowship in hematology and oncology at Duke University.